| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60f7db8bbbcce9810801e2e6b41f3a70 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-08 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-557 |
| filingDate |
1976-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_099e6ce8045b6db4cb2f6513907a2bad |
| publicationDate |
1978-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-2659241-A1 |
| titleOfInvention |
XANTHINOL OROTATE |
| abstract |
Xanthinol orotate of formula (I) is new: (I) can be used as pharmaceuticals, cosmetics and in veterinary medicine. (I) promotes blood circulation, the mental alertness of humans and the ability of rats to learn. (I) lowers the fat content of blood and restricts the general regeneration process of cells without having any harmful effects. The toxicity of (I) is practically negligible, Suitable therapeutic doses are 50-1000 (pref. 200)mg (I) is soluble in water (cf. other orotic acid salts which are sparingly soluble) and solns. of up to 20% can be stored for unlimited periods. (I) itself is stable (I) can be combined with other active ingredients e.g. Clifibrat, or painkillers e.g. acetyl salicylic acid or stimulants eg caffeine. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5750575-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7423041-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7247639-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5641783-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7902360-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0761222-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5777117-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5824677-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5801181-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6117998-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7202252-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6489332-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6495687-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5837703-A |
| priorityDate |
1976-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |